Cargando…
Selenium nanoparticles enhance the efficacy of homologous vaccine against the highly pathogenic avian influenza H5N1 virus in chickens
A proper vaccination against avian influenza viruses in chicken can significantly reduce the risk of human infection. Egypt has the highest number of recorded humans highly pathogenic avian influenza (HPAI)-H5N1 infections worldwide despite the widespread use of homologous vaccines in poultry. Enhan...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072940/ https://www.ncbi.nlm.nih.gov/pubmed/35531142 http://dx.doi.org/10.1016/j.sjbs.2021.11.051 |
_version_ | 1784701173821865984 |
---|---|
author | Yehia, Nahed AbdelSabour, Mohammed A. Erfan, Ahmed M. Mohammed Ali, Zeinab Soliman, Reem A. Samy, Ahmed Mohamed Soliman, Mohamed Abd El-Hack, Mohamed E. El-Saadony, Mohamed T. Ahmed, Kawkab A. |
author_facet | Yehia, Nahed AbdelSabour, Mohammed A. Erfan, Ahmed M. Mohammed Ali, Zeinab Soliman, Reem A. Samy, Ahmed Mohamed Soliman, Mohamed Abd El-Hack, Mohamed E. El-Saadony, Mohamed T. Ahmed, Kawkab A. |
author_sort | Yehia, Nahed |
collection | PubMed |
description | A proper vaccination against avian influenza viruses in chicken can significantly reduce the risk of human infection. Egypt has the highest number of recorded humans highly pathogenic avian influenza (HPAI)-H5N1 infections worldwide despite the widespread use of homologous vaccines in poultry. Enhancing H5N1 vaccine efficacy is ultimately required to better control HPAI-H5N1. The aim of this study is to boost chicken immunity by combined with inactivated HPAI-H5N1 with selenium nanoparticles (SeNPs). The chickens groups 1–3 were fed diets supplemented with SeNPs concentrations (0.25, 0.5, and 1 mg/kg) for 3 weeks and then vaccinated (inactivated HPAI-H5N1). while groups 4,5 and 6 were fed with SeNPs free diets and administered with 0.5 ml of the vaccine combined with 0.02, 0.06, and 0.1 mg/dose of SeNPs and then all groups were challenged with homologous virus 3 weeks post-vaccination (WPV). Group 7, 8 were used as control positive and negative respectively. At 4, 5, and 6 WPV, antibody titer was considerably higher in the group fed a meal supplemented with 1 mg SeNPs/kg. In contrast, both methods of SeNPs supplementation significantly increased the Interleukin 2 (IL2), Interleukin 6 (IL6), and Interferon γ (IFNγ) expressions in the blood cells in a dose-dependent manner, with a higher expression observed in the group that was vaccinated with 0.1 mg/dose. After the challenge, all groups that received SeNPs via diet or vaccines dose showed significant reduction in viral shedding and milder inflammation in lung, trachea, spleen, and liver in addition to higher expression of IL2, IL6, and IFNγ, with the highest expression observed in the group that was vaccinated with 0.1 mg/dose compared the plain vaccinated group. The groups of 1 mg SeNPs/kg and combined vaccinated with 0.1 mg/dose showed the best vaccine efficacy. However, the group vaccinated with 0.1 mg/dose showed the earliest reduction in viral shedding. Overall, SeNPs supplementation in the diet and the administration of the vaccine formula with SeNPs could enhance vaccine efficacy and provide better protection against HPAI-H5N1 in chickens by enhancing cellular immunity and reducing inflammation. We recommend using SeNPs as a vaccine combination or feeding with diet to increase the immunity and vaccine efficacy against H5N1. |
format | Online Article Text |
id | pubmed-9072940 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90729402022-05-07 Selenium nanoparticles enhance the efficacy of homologous vaccine against the highly pathogenic avian influenza H5N1 virus in chickens Yehia, Nahed AbdelSabour, Mohammed A. Erfan, Ahmed M. Mohammed Ali, Zeinab Soliman, Reem A. Samy, Ahmed Mohamed Soliman, Mohamed Abd El-Hack, Mohamed E. El-Saadony, Mohamed T. Ahmed, Kawkab A. Saudi J Biol Sci Original Article A proper vaccination against avian influenza viruses in chicken can significantly reduce the risk of human infection. Egypt has the highest number of recorded humans highly pathogenic avian influenza (HPAI)-H5N1 infections worldwide despite the widespread use of homologous vaccines in poultry. Enhancing H5N1 vaccine efficacy is ultimately required to better control HPAI-H5N1. The aim of this study is to boost chicken immunity by combined with inactivated HPAI-H5N1 with selenium nanoparticles (SeNPs). The chickens groups 1–3 were fed diets supplemented with SeNPs concentrations (0.25, 0.5, and 1 mg/kg) for 3 weeks and then vaccinated (inactivated HPAI-H5N1). while groups 4,5 and 6 were fed with SeNPs free diets and administered with 0.5 ml of the vaccine combined with 0.02, 0.06, and 0.1 mg/dose of SeNPs and then all groups were challenged with homologous virus 3 weeks post-vaccination (WPV). Group 7, 8 were used as control positive and negative respectively. At 4, 5, and 6 WPV, antibody titer was considerably higher in the group fed a meal supplemented with 1 mg SeNPs/kg. In contrast, both methods of SeNPs supplementation significantly increased the Interleukin 2 (IL2), Interleukin 6 (IL6), and Interferon γ (IFNγ) expressions in the blood cells in a dose-dependent manner, with a higher expression observed in the group that was vaccinated with 0.1 mg/dose. After the challenge, all groups that received SeNPs via diet or vaccines dose showed significant reduction in viral shedding and milder inflammation in lung, trachea, spleen, and liver in addition to higher expression of IL2, IL6, and IFNγ, with the highest expression observed in the group that was vaccinated with 0.1 mg/dose compared the plain vaccinated group. The groups of 1 mg SeNPs/kg and combined vaccinated with 0.1 mg/dose showed the best vaccine efficacy. However, the group vaccinated with 0.1 mg/dose showed the earliest reduction in viral shedding. Overall, SeNPs supplementation in the diet and the administration of the vaccine formula with SeNPs could enhance vaccine efficacy and provide better protection against HPAI-H5N1 in chickens by enhancing cellular immunity and reducing inflammation. We recommend using SeNPs as a vaccine combination or feeding with diet to increase the immunity and vaccine efficacy against H5N1. Elsevier 2022-04 2021-11-25 /pmc/articles/PMC9072940/ /pubmed/35531142 http://dx.doi.org/10.1016/j.sjbs.2021.11.051 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Yehia, Nahed AbdelSabour, Mohammed A. Erfan, Ahmed M. Mohammed Ali, Zeinab Soliman, Reem A. Samy, Ahmed Mohamed Soliman, Mohamed Abd El-Hack, Mohamed E. El-Saadony, Mohamed T. Ahmed, Kawkab A. Selenium nanoparticles enhance the efficacy of homologous vaccine against the highly pathogenic avian influenza H5N1 virus in chickens |
title | Selenium nanoparticles enhance the efficacy of homologous vaccine against the highly pathogenic avian influenza H5N1 virus in chickens |
title_full | Selenium nanoparticles enhance the efficacy of homologous vaccine against the highly pathogenic avian influenza H5N1 virus in chickens |
title_fullStr | Selenium nanoparticles enhance the efficacy of homologous vaccine against the highly pathogenic avian influenza H5N1 virus in chickens |
title_full_unstemmed | Selenium nanoparticles enhance the efficacy of homologous vaccine against the highly pathogenic avian influenza H5N1 virus in chickens |
title_short | Selenium nanoparticles enhance the efficacy of homologous vaccine against the highly pathogenic avian influenza H5N1 virus in chickens |
title_sort | selenium nanoparticles enhance the efficacy of homologous vaccine against the highly pathogenic avian influenza h5n1 virus in chickens |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072940/ https://www.ncbi.nlm.nih.gov/pubmed/35531142 http://dx.doi.org/10.1016/j.sjbs.2021.11.051 |
work_keys_str_mv | AT yehianahed seleniumnanoparticlesenhancetheefficacyofhomologousvaccineagainstthehighlypathogenicavianinfluenzah5n1virusinchickens AT abdelsabourmohammeda seleniumnanoparticlesenhancetheefficacyofhomologousvaccineagainstthehighlypathogenicavianinfluenzah5n1virusinchickens AT erfanahmedm seleniumnanoparticlesenhancetheefficacyofhomologousvaccineagainstthehighlypathogenicavianinfluenzah5n1virusinchickens AT mohammedalizeinab seleniumnanoparticlesenhancetheefficacyofhomologousvaccineagainstthehighlypathogenicavianinfluenzah5n1virusinchickens AT solimanreema seleniumnanoparticlesenhancetheefficacyofhomologousvaccineagainstthehighlypathogenicavianinfluenzah5n1virusinchickens AT samyahmed seleniumnanoparticlesenhancetheefficacyofhomologousvaccineagainstthehighlypathogenicavianinfluenzah5n1virusinchickens AT mohamedsolimanmohamed seleniumnanoparticlesenhancetheefficacyofhomologousvaccineagainstthehighlypathogenicavianinfluenzah5n1virusinchickens AT abdelhackmohamede seleniumnanoparticlesenhancetheefficacyofhomologousvaccineagainstthehighlypathogenicavianinfluenzah5n1virusinchickens AT elsaadonymohamedt seleniumnanoparticlesenhancetheefficacyofhomologousvaccineagainstthehighlypathogenicavianinfluenzah5n1virusinchickens AT ahmedkawkaba seleniumnanoparticlesenhancetheefficacyofhomologousvaccineagainstthehighlypathogenicavianinfluenzah5n1virusinchickens |